Iboga, ibogaine, noribogaine & 18-MC
Page 6 (2013-2017)
Mazoyer et al. (2013). Fatal case of a 27-year-old male after taking iboga in withdrawal treatment: GC-MS/MS determination of ibogaine and ibogamine in iboga roots and postmortem biological material. Journal of Forensic Sciences.
Meyer et al. (2014). A qualitative/quantitative approach for the detection of 37 tryptamine-derived designer drugs, 5 beta-carbolines, ibogaine, and yohimbine in human urine and plasma using standard urine screening and multi-analyte approaches. Analytical and Bioanalytical Chemistry.
Arias et al. (2015). Coronaridine congeners inhibit human α3β4 nicotinic acetylcholine receptors by interacting with luminal and non-luminal sites. The International Journal of Biochemistry & Cell Biology.
Ohishi et al. (2015). Coronaridine, an iboga type alkaloid from Tabernaemontana divaricata, inhibits the Wnt signaling pathway by decreasing β-catenin mRNA expression. Bioorganic & Medicinal Chemistry Letters.
Heink, Katsikas & Lange-Altman (2017). Examination of the phenomenology of the ibogaine treatment experience: Role of altered states of consciousness and psychedelic experiences. Journal of Psychoactive Drugs.